Target intelligence / Profile preview

Keratin 18 pseudogene 68 (KRT18P68)

Target
KRT18P68
Molecular classification
Other (Pseudogene)
01

Overview

Keratin 18 pseudogene 68 (KRT18P68) is classified as a pseudogene—an inactivated genomic sequence that shares homology with the functional keratin 18 gene (KRT18) but does not code for a functional protein. The canonical, protein-coding gene in the region is KRT18, which encodes a structural intermediate filament protein expressed in simple epithelial tissues and is widely studied for its roles in tissue structure, epithelial tumor diagnosis, and cell regulation[1][2][3][4]. However, KRT18P68 itself lacks evidence for a coding, functional, or therapeutic role and does not participate in biological pathways, nor are there associated drugs or disease roles reported in biomedical or pharmacological sources. Is there something wrong with this target? Yes, referring to "KRT18P68" in the context of a therapeutic target or functional receptor is incorrect, as it is a **pseudogene** and current evidence does not suggest it functions at a protein or RNA level relevant to molecular targeting in medicine or biology. The functional gene of importance is "Keratin 18" (KRT18), not "KRT18P68." As such, queries or analyses expecting structure/function, pharmacology, or disease links relate to the functional KRT18, not this pseudogene. Summary of context: - Functional and clinical roles—such as those in tumor diagnosis, apoptosis regulation, and cytoskeletal structure—are attributed to **Keratin 18 (KRT18)**, not KRT18P68[1][2][3][4]. - Pseudogenes like KRT18P68 generally do not encode protein and are not established molecular drug targets. - No drugs, mechanisms, biomarkers, or disease associations are recorded for KRT18P68 in research or clinical databases. If you intended the functional **Keratin 18** target, please specify "Keratin 18 (KRT18)." Conversely, if your search is specifically about the pseudogene KRT18P68, it should be excluded from most structured target databases as a non-target entity.

Other names
KRT18P68keratin 18 pseudogene 68

Beyond the preview

Go deeper on Keratin 18 pseudogene 68 (KRT18P68).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 18 pseudogene 68 (KRT18P68).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call